89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up

Frederike Bensch(University Medical Center Groningen), C.P. Schröder(University Medical Center Groningen)

European Journal of Nuclear Medicine and Molecular Imaging

July 29, 2018

10.1007/s00259-018-4099-8

Cited by 137

Related Papers

Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

|Annals of Oncology|2017|396